FTC, Utah, LA County regulatory lawsuit: Can Hims & Hers Health stock avoid deeper losses?

Traders Union
All News
Stocks
Hims & Hers down 0.96% at $27.9 today

Highlights

Hims & Hers Health and certain executives are facing a securities class action lawsuit after a federal complaint by the FTC and local authorities over alleged privacy and subscription consent violations.
The firm is accused of improperly sharing consumer health data with advertisers and prematurely charging customers for prescriptions within the disputed period of August 4, 2025, to July 29, 2026.
Shares closed at $27.9, with mixed technical indicators and a forecasted range of $27.14 to $28.66 and a down probability of 55% for the coming days.

Legal and reputational risks rise as lawsuit alleges consumer data breaches

Hims & Hers Health, Inc. and certain executives recently became the subject of a securities class action lawsuit following a federal complaint brought by the FTC, State of Utah, and County of Los Angeles on July 29, 2026, as reported by PR Newswire. The lawsuit alleges that the company shared consumer health information with third-party advertisers, charged customers prematurely for prescriptions after intake forms, and violated the Restore Online Shoppers' Confidence Act by enrolling customers in recurring subscriptions without proper consent. According to GlobeNewswire, shareholders who acquired stock between August 4, 2025, and July 29, 2026, have until November 2, 2026, to file as lead plaintiffs, highlighting ongoing legal uncertainty and reputational risks for the firm.

Technical mixed signals persist as price straddles pivotal averages

On the technical front, HIMS recently closed at $27.9, positioned above the MA-20 but still trading below the MA-50 and MA-200. The Ichimoku Kijun at $27.81 serves as immediate support on the daily chart. Momentum signals are mixed: MACD indicates strong selling, ADX is neutral, RSI is in sell territory near 49, and the Stoch RSI sits in overbought territory. CCI is neutral, while Bull/Bear Power reflects strong intraday buyer dominance despite divergence from other oscillators, and the Awesome Oscillator remains neutral.

Neutral short-term outlook as price volatility defines trading range

Over the next few trading sessions, HIMS is likely to move sideways within a typical volatility range of $27.14 to $28.66. Price action is expected to remain inside these bounds, with the probability of a down move at 55% and up move at 45%. A bullish scenario develops if resistance near the range high is breached, while a bearish outcome would be triggered if price falls below immediate support at the lower boundary.

Viktoras Karapetjanc, Traders Union expert, believes Hims & Hers faces heightened legal and reputational risks following the FTC-led class action. He notes the stock holds above short-term averages but remains subdued below medium and long-term technical barriers. Macro and sentiment forces are likely to keep investors cautious as the regulatory story unfolds. "Momentum is mixed and headline risk looms for now, but any positive legal update could quickly shift the outlook in HIMS favor."

Earlier, analysts noted that Hims & Hers Health faced ongoing legal and regulatory headwinds, with short-term technical momentum clashing against longer-term weakness. The latest update deepens these risks with new class action allegations and mixed momentum signals, making it critical for investors to monitor the $27.14 immediate support as a potential inflection point in the coming sessions.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.